Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Beacon Topco, Inc.

CLYD · Life Sciences · 4 alerts · CIK 2094256

Shares outstanding
100Latest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Beacon Topco, Inc. filings on SEC EDGAR ↗

4:44 PM ET 10-Q
Financial Results

Beacon Topco Q3 2026 Results: Net Loss of $6.1M, Loss Narrows

For the nine months ended September 30, 2026, Beacon Topco reported a net loss of $22.2 million, a significant reduction from the $55.4 million loss in the prior year period. The company maintained a cash position of $49.2 million and plans to rename itself Clywedog Therapeutics Holdings, Inc. following a pending merger transaction.

Key figure
Net loss $6.1M
4:19 PM ET 8-K
M&A Deal

Beacon Topco M&A Deal with Clywedog Therapeutics, Inc.

Beacon Topco, Inc. entered into a third amendment to its merger agreement with Clywedog Therapeutics, Inc. and Barinthus Biotherapeutics plc. The amendment updates the expected closing timeline and extends the 'End Date' for the merger to November 13, 2026.

Counterparty
Clywedog Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.